508 related articles for article (PubMed ID: 34191698)
1. Role of Gut Microbiota in Multiple Sclerosis and Potential Therapeutic Implications.
Wang X; Liang Z; Wang S; Ma D; Zhu M; Feng J
Curr Neuropharmacol; 2022; 20(7):1413-1426. PubMed ID: 34191698
[TBL] [Abstract][Full Text] [Related]
2. The Gut-Brain Axis in Multiple Sclerosis. Is Its Dysfunction a Pathological Trigger or a Consequence of the Disease?
Parodi B; Kerlero de Rosbo N
Front Immunol; 2021; 12():718220. PubMed ID: 34621267
[TBL] [Abstract][Full Text] [Related]
3. Interaction of the Gut Microbiome and Immunity in Multiple Sclerosis: Impact of Diet and Immune Therapy.
Yadav SK; Ito K; Dhib-Jalbut S
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834203
[TBL] [Abstract][Full Text] [Related]
4. Gut-oriented interventions in patients with multiple sclerosis: fact or fiction?
Martinelli V; Albanese M; Altieri M; Annovazzi P; Arabi S; Bucello S; Caleri F; Cerqua R; Costanzi C; Cottone S; Dalla Costa G; Direnzo V; Fantozzi R; Favaretto A; Lorefice L; Montini F; Noce A; Plewnia K; Repice AM; Sacco R; Vecchio D
Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):935-946. PubMed ID: 35179760
[TBL] [Abstract][Full Text] [Related]
5. Obesity induced gut dysbiosis contributes to disease severity in an animal model of multiple sclerosis.
Shahi SK; Ghimire S; Lehman P; Mangalam AK
Front Immunol; 2022; 13():966417. PubMed ID: 36164343
[TBL] [Abstract][Full Text] [Related]
6. Gut Microbiota in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Current Applications and Future Perspectives.
Chu F; Shi M; Lang Y; Shen D; Jin T; Zhu J; Cui L
Mediators Inflamm; 2018; 2018():8168717. PubMed ID: 29805314
[TBL] [Abstract][Full Text] [Related]
7. Oxymatrine ameliorates experimental autoimmune encephalomyelitis by rebalancing the homeostasis of gut microbiota and reducing blood-brain barrier disruption.
Zhang ML; Li WX; Wang XY; Wu YL; Chen XF; Zhang H; Yang LQ; Wu CZ; Zhang SQ; Chen YL; Feng KR; Wang B; Niu L; Kong DX; Tang JF
Front Cell Infect Microbiol; 2022; 12():1095053. PubMed ID: 36710971
[TBL] [Abstract][Full Text] [Related]
8. The role of gut microbiome and associated metabolome in the regulation of neuroinflammation in multiple sclerosis and its implications in attenuating chronic inflammation in other inflammatory and autoimmune disorders.
Dopkins N; Nagarkatti PS; Nagarkatti M
Immunology; 2018 Jun; 154(2):178-185. PubMed ID: 29392733
[TBL] [Abstract][Full Text] [Related]
9. The second brain: The connection between gut microbiota composition and multiple sclerosis.
Farshbafnadi M; Agah E; Rezaei N
J Neuroimmunol; 2021 Nov; 360():577700. PubMed ID: 34482269
[TBL] [Abstract][Full Text] [Related]
10. Feeding the gut microbiome: impact on multiple sclerosis.
Bronzini M; Maglione A; Rosso R; Matta M; Masuzzo F; Rolla S; Clerico M
Front Immunol; 2023; 14():1176016. PubMed ID: 37304278
[TBL] [Abstract][Full Text] [Related]
11. The importance of gut-brain axis and use of probiotics as a treatment strategy for multiple sclerosis.
Kumar N; Sahoo NK; Mehan S; Verma B
Mult Scler Relat Disord; 2023 Mar; 71():104547. PubMed ID: 36805171
[TBL] [Abstract][Full Text] [Related]
12. Impact of Disease-Modifying Therapies on Gut-Brain Axis in Multiple Sclerosis.
Del Negro I; Pez S; Versace S; Marziali A; Gigli GL; Tereshko Y; Valente M
Medicina (Kaunas); 2023 Dec; 60(1):. PubMed ID: 38276041
[TBL] [Abstract][Full Text] [Related]
13. Gut commensals, dysbiosis, and immune response imbalance in the pathogenesis of multiple sclerosis.
Brown J; Quattrochi B; Everett C; Hong BY; Cervantes J
Mult Scler; 2021 May; 27(6):807-811. PubMed ID: 32507072
[TBL] [Abstract][Full Text] [Related]
14. The "Gut Feeling": Breaking Down the Role of Gut Microbiome in Multiple Sclerosis.
Freedman SN; Shahi SK; Mangalam AK
Neurotherapeutics; 2018 Jan; 15(1):109-125. PubMed ID: 29204955
[TBL] [Abstract][Full Text] [Related]
15. Combined therapies to treat complex diseases: The role of the gut microbiota in multiple sclerosis.
Calvo-Barreiro L; Eixarch H; Montalban X; Espejo C
Autoimmun Rev; 2018 Feb; 17(2):165-174. PubMed ID: 29191793
[TBL] [Abstract][Full Text] [Related]
16. Dietary ellagic acid therapy for CNS autoimmunity: Targeting on Alloprevotella rava and propionate metabolism.
Han B; Shi L; Bao MY; Yu FL; Zhang Y; Lu XY; Wang Y; Li DX; Lin JC; Jia W; Li X; Zhang Y
Microbiome; 2024 Jun; 12(1):114. PubMed ID: 38915127
[TBL] [Abstract][Full Text] [Related]
17. Gut-Microbiota, and Multiple Sclerosis: Background, Evidence, and Perspectives.
Altieri C; Speranza B; Corbo MR; Sinigaglia M; Bevilacqua A
Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839299
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiome and multiple sclerosis: New insights and perspective.
Esmaeil Amini M; Shomali N; Bakhshi A; Rezaei S; Hemmatzadeh M; Hosseinzadeh R; Eslami S; Babaie F; Aslani S; Torkamandi S; Mohammadi H
Int Immunopharmacol; 2020 Nov; 88():107024. PubMed ID: 33182024
[TBL] [Abstract][Full Text] [Related]
19. Strength Exercise Confers Protection in Central Nervous System Autoimmunity by Altering the Gut Microbiota.
Chen H; Shen L; Liu Y; Ma X; Long L; Ma X; Ma L; Chen Z; Lin X; Si L; Chen X
Front Immunol; 2021; 12():628629. PubMed ID: 33796102
[TBL] [Abstract][Full Text] [Related]
20. Targeting gut microbiota: new therapeutic opportunities in multiple sclerosis.
Kujawa D; Laczmanski L; Budrewicz S; Pokryszko-Dragan A; Podbielska M
Gut Microbes; 2023 Dec; 15(2):2274126. PubMed ID: 37979154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
